Manchester: A new drug could ease the distress of men and women who suffer
from baldness, according to researchers from The University of
Manchester’s Centre for Dermatology Research.
The study from the laboratory of Prof Ralf Paus, is published today (8 May) in the open access journal PLOS Biology. It shows that a drug originally designed as a treatment for osteoporosis has a dramatic stimulatory effect on human hair follicles donated by patients undergoing hair transplantation surgery.
The study from the laboratory of Prof Ralf Paus, is published today (8 May) in the open access journal PLOS Biology. It shows that a drug originally designed as a treatment for osteoporosis has a dramatic stimulatory effect on human hair follicles donated by patients undergoing hair transplantation surgery.
